Regulators of epidermal growth and differentiation

表皮生长和分化的调节剂

基本信息

  • 批准号:
    10294731
  • 负责人:
  • 金额:
    $ 48.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-02-17 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract Background: The prevailing model of epidermal differentiation is that transcription factors recruit RNA Polymerase II to differentiation gene promoters only upon the induction of differentiation. It is possible that mechanisms downstream of transcription initiation such as transcriptional elongation can have major impacts on regulating epidermal growth and differentiation. We have shown that specific elongation factors such as ELL and ELL2 are necessary for epidermal growth while SPT6 is essential for differentiation through the control of transcription elongation. Objective/hypothesis: This proposal seeks to understand the regulation of epidermal stem and progenitor cell self-renewal and differentiation through transcription elongation. We have found that up to 30% of induced epidermal differentiation genes contain promoter proximal paused RNA polymerase II in stem and progenitor cells. Upon differentiation, specific elongation factors such as SPT6 are necessary to promote the transcriptional elongation of these paused differentiation genes. In stem and progenitor cells there are also elongation factors that promote the transcription of growth and proliferation genes to allow for epidermal renewal. Specific Aims: (1) The role of transcription elongation factors on epidermal growth and differentiation (2) Mechanisms on how elongation factors control epidermal growth and differentiation. Study Design: To study epidermal homeostasis in a more clinically relevant setting, we generate 3-dimensionally intact human skin, containing human epidermal cells (that have been permanently knocked down for transcription elongation factors) in the context of human dermal stroma and basement membrane, regenerated on immune compromised mice. By using this model, we can perform loss of function experiments on the transcription elongation factors in regenerated human skin to characterize their role in epidermal growth and differentiation. We will also use chromatin immunoprecipitations followed by next generation sequencing to determine which genes the elongation factors bind and regulate.
项目摘要/摘要 背景:表皮分化的普遍模式是转录 因子仅在分化基因启动子上招募RNA聚合酶II 诱导分化。有可能转录下游的机制 转录延伸等启动可能对调控产生重大影响 表皮生长和分化。我们已经证明了特定的伸长系数 如ELL和ELL2是表皮生长所必需,而SPT6是表皮生长所必需的 通过控制转录伸长进行分化。 目的/假设:这项提议试图了解表皮的调节 干细胞和祖细胞通过转录延伸进行自我更新和分化。 我们发现,高达30%的诱导表皮分化基因含有 启动子近端暂停了干细胞和祖细胞中的RNA聚合酶II。vt.在.的基础上 分化,特殊的伸长因子如SPT6是必要的促进 这些暂停的分化基因的转录延长。在茎和祖细胞中 细胞也有伸长因子,可以促进转录生长和 增殖基因,以允许表皮更新。 具体目的:(1)转录延伸因子在表皮生长和生长中的作用 分化(2)伸长因子控制表皮生长的机制 差异化。 研究设计:为了在更具临床相关性的环境中研究表皮动态平衡,我们 生成三维完整的人类皮肤,包含人类表皮细胞(即 已经被永久地去除转录延伸因子)在上下文中 人体真皮基质和基底膜,免疫后再生 受损的老鼠。利用这一模型,我们可以进行功能损失实验。 人再生皮肤中转录延伸因子的作用研究 在表皮的生长和分化中。我们还将使用染色质免疫沉淀 然后进行下一代测序,以确定哪些基因是延长因子 约束和规范。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GEORGE L SEN其他文献

GEORGE L SEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GEORGE L SEN', 18)}}的其他基金

Regulation of Human Tumorigensis by Cancer Specific NXF1 Adaptor Proteins
癌症特异性 NXF1 接头蛋白对人类肿瘤发生的调节
  • 批准号:
    10411472
  • 财政年份:
    2022
  • 资助金额:
    $ 48.03万
  • 项目类别:
Regulation of epidermal growth and differentiation through mRNA export
通过 mRNA 输出调节表皮生长和分化
  • 批准号:
    10675700
  • 财政年份:
    2022
  • 资助金额:
    $ 48.03万
  • 项目类别:
Regulation of Human Tumorigensis by Cancer Specific NXF1 Adaptor Proteins
癌症特异性 NXF1 接头蛋白对人类肿瘤发生的调节
  • 批准号:
    10596156
  • 财政年份:
    2022
  • 资助金额:
    $ 48.03万
  • 项目类别:
Post-Transcriptional Regulators of Epidermal Homeostasis and Neoplasia
表皮稳态和肿瘤的转录后调节因子
  • 批准号:
    10161730
  • 财政年份:
    2018
  • 资助金额:
    $ 48.03万
  • 项目类别:
Post-Transcriptional Regulators of Epidermal Homeostasis and Neoplasia
表皮稳态和肿瘤的转录后调节因子
  • 批准号:
    9916713
  • 财政年份:
    2018
  • 资助金额:
    $ 48.03万
  • 项目类别:
Regulation of Human Epidermal Tumorigenesis by the mRNA Degradation Pathway
mRNA 降解途径调控人表皮肿瘤发生
  • 批准号:
    10532171
  • 财政年份:
    2018
  • 资助金额:
    $ 48.03万
  • 项目类别:
Post-Transcriptional Regulators of Epidermal Homeostasis and Neoplasia
表皮稳态和肿瘤的转录后调节因子
  • 批准号:
    10402316
  • 财政年份:
    2018
  • 资助金额:
    $ 48.03万
  • 项目类别:
Regulation of Human Epidermal Tumorigenesis by the mRNA Degradation Pathway
mRNA 降解途径调控人表皮肿瘤发生
  • 批准号:
    10053717
  • 财政年份:
    2018
  • 资助金额:
    $ 48.03万
  • 项目类别:
Regulation of Human Epidermal Tumorigenesis by the mRNA Degradation Pathway
mRNA 降解途径调控人表皮肿瘤发生
  • 批准号:
    10304861
  • 财政年份:
    2018
  • 资助金额:
    $ 48.03万
  • 项目类别:
Limbal Stem Cell Fate and Corneal Specific Enhancers
角膜缘干细胞命运和角膜特异性增强剂
  • 批准号:
    9039606
  • 财政年份:
    2015
  • 资助金额:
    $ 48.03万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 48.03万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.03万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 48.03万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.03万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 48.03万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 48.03万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.03万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 48.03万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 48.03万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.03万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了